Condition: Pharmacogenomic Drug Interaction · Sponsor: University of Florida
The objectives of this study are to (1) test the feasibility of the clinical implementation of preemptive pharmacogenetic (PGx) testing in the emergency department (ED) and (2) determine if PGx testing (with appropriate decision support) decreases ED return visits and hospitalizations. We will conduct a randomized, controlled, pragmatic clinical trial assessing both the real-world effectiveness as well as implementation outcomes using a targeted PGx testing panel in several UF Health EDs.
This description comes directly from the study's public registry record.
Erica N Elwood, MHA · 3522736007 · erica.elwood@cop.ufl.edu
Always discuss trial participation with your own doctor first.
| UF Health Emergency Department | Gainesville, Florida, United States | Not Yet Recruiting |
| UF Health Jacksonville Downtown Emergency Department | Jacksonville, Florida, United States | Recruiting |
| UF Health Jacksonville North Emergency Department | Jacksonville, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06448091